Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)

Clinical trial NCT00557622 · TERMINATED

Trial details

NCT number: NCT00557622
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Post-Traumatic Stress Disorder Stress Disorders, Post-Traumatic

Start date: 2008-01-25
Primary completion: 2008-12-11
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.